FDA Clears New Genentech Breast Cancer Drug, in Combo With Herceptin
22:23 EDT 8 Jun 2012 | Xconomy
The FDA gave Genentech the news it was hoping for late today, by giving the South San Francisco-based biotech company clearance to start selling a new drug for about one-fourth of women with breast cancer. Genentech, a unit of Switzerland-based Roche..
Original Article: FDA Clears New Genentech Breast Cancer Drug, in Combo With Herceptin
More From BioPortfolio on "FDA Clears New Genentech Breast Cancer Drug, in Combo With Herceptin"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
